AcquisitionOther

2seventy bio, Inc. acquired target

Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.

Deal tape row

2seventy bio, Inc. -> target

Stockholder: In January 2021, we announced a transformative milestone for bluebird bio, Inc.—our intent to separate our oncology portfolio and programs from our severe genetic disease portfolio and programs, thereby creating two independent, publicly traded co

Open source record (SEC) ↗

Have a question, or want to talk something through?

Let's Talk